Mettler-Toledo International Inc. (NYSE:MTD) Shares Acquired by Capital Research Global Investors

Capital Research Global Investors increased its stake in Mettler-Toledo International Inc. (NYSE:MTD) by 0.1% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 14,279 shares of the medical instruments supplier’s stock after acquiring an additional 16 shares during the quarter. Capital Research Global Investors owned approximately 0.07% of Mettler-Toledo International worth $17,473,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of the stock. Capital International Inc. CA boosted its stake in Mettler-Toledo International by 0.3% during the fourth quarter. Capital International Inc. CA now owns 17,730 shares of the medical instruments supplier’s stock worth $21,696,000 after buying an additional 55 shares during the period. Epoch Investment Partners Inc. increased its holdings in Mettler-Toledo International by 11.2% in the 4th quarter. Epoch Investment Partners Inc. now owns 94,407 shares of the medical instruments supplier’s stock valued at $115,524,000 after purchasing an additional 9,473 shares during the last quarter. Capital International Sarl lifted its stake in Mettler-Toledo International by 6.3% during the fourth quarter. Capital International Sarl now owns 11,521 shares of the medical instruments supplier’s stock worth $14,098,000 after purchasing an additional 681 shares in the last quarter. Champlain Investment Partners LLC boosted its position in shares of Mettler-Toledo International by 4.2% during the fourth quarter. Champlain Investment Partners LLC now owns 119,665 shares of the medical instruments supplier’s stock worth $146,432,000 after buying an additional 4,818 shares during the period. Finally, Farringdon Capital Ltd. acquired a new stake in shares of Mettler-Toledo International in the fourth quarter valued at $841,000. Institutional investors and hedge funds own 95.07% of the company’s stock.

Insider Buying and Selling

In other Mettler-Toledo International news, insider Gerry Keller sold 600 shares of the company’s stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total transaction of $810,804.00. Following the completion of the sale, the insider now directly owns 6 shares of the company’s stock, valued at $8,108.04. This represents a 99.01 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Christian Magloth sold 790 shares of the stock in a transaction that occurred on Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the sale, the insider now directly owns 734 shares of the company’s stock, valued at $964,248.46. The trade was a 51.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.94% of the stock is owned by company insiders.

Mettler-Toledo International Stock Performance

Shares of MTD stock opened at $971.31 on Tuesday. Mettler-Toledo International Inc. has a 1 year low of $946.69 and a 1 year high of $1,546.93. The firm has a market cap of $20.24 billion, a price-to-earnings ratio of 23.97, a PEG ratio of 3.30 and a beta of 1.28. The stock’s 50-day moving average is $1,178.59 and its two-hundred day moving average is $1,255.16.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 EPS for the quarter, topping the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. As a group, research analysts predict that Mettler-Toledo International Inc. will post 42.71 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on MTD shares. Evercore ISI increased their target price on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an “outperform” rating in a report on Monday, February 10th. Robert W. Baird upped their target price on shares of Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the stock a “neutral” rating in a research note on Monday, February 10th. Wells Fargo & Company decreased their price target on shares of Mettler-Toledo International from $1,400.00 to $1,125.00 and set an “equal weight” rating for the company in a research note on Thursday, April 17th. Finally, Citigroup upgraded shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,400.00 price objective on the stock in a report on Monday, April 7th. One analyst has rated the stock with a sell rating, five have issued a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $1,346.13.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.